George Martin, MD
Dermatology · Kihei, HINPI 1134147994
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (46.5%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by AbbVie at 46.6% of the total. Reporting peaked in 2022 at $734,310 and has fallen 85.8% since, to $104,394 in 2025. Among dermatology clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 589 payments — averaging $3350.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$920K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$692K
- Bristol Myers Squibb$64K
- E.r. Squibb & Sons, L.L.C.$49K
- Dermavant Sciences, Inc.$45K
- LEO Pharma Inc.$36K
- plus $168K from 24 others
What the payments were for
- Consulting fees$181,9899%
- Speaking & faculty fees$752,24338%
- Grants$917,25046%
- Travel & lodging$36,4052%
- Food & beverage$20,9801%
- Education$64,3433%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 77 | $919,656 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 50 | $691,701 |
| Bristol Myers Squibb | 9 | $64,313 |
| E.r. Squibb & Sons, L.L.C. | 58 | $48,819 |
| Dermavant Sciences, Inc. | 33 | $45,332 |
| LEO Pharma Inc. | 44 | $35,603 |
| UCB, Inc. | 44 | $31,664 |
| Pfizer | 16 | $30,781 |
| Incyte Corporation | 38 | $27,798 |
| Novartis | 33 | $20,567 |
| Almirall LLC | 10 | $13,908 |
| Sun Pharmaceutical Industries Inc. | 22 | $11,946 |
| Regeneron Healthcare Solutions, Inc. | 26 | $7,476 |
| DUSA Pharmaceuticals, Inc. | 3 | $6,928 |
| Johnson & Johnson | 17 | $5,884 |
| Aclaris Therapeutics, Inc. | 6 | $2,898 |
| Sanofi | 17 | $2,145 |
| Lilly USA, LLC | 12 | $1,870 |
| Organon | 8 | $1,220 |
| Amgen(2 entities) | 13 | $583 |
| Galderma Laboratories, L.p. | 12 | $533 |
| Arcutis Biotherapeutics, Inc. | 13 | $425 |
| Genentech USA, Inc. | 10 | $336 |
| Biofrontera Inc. | 9 | $295 |
| Janssen Scientific Affairs, LLC | 3 | $196 |
| Sanofi-aventis U.S. LLC | 2 | $129 |
| Regeneron | 1 | $107 |
| Bausch Health US, LLC | 1 | $45 |
| Blueprint Medicines Corporation | 1 | $29 |
| Merz North America, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,973,210 in reported general payments places this provider in the 95th percentile of 67 dermatology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 71 | $4,913 |
| Tacrolimus | 16 | $1,989 |
| Mupirocin | 170 | $1,368 |
| Imiquimod | 18 | $542 |
| ValacyclovirValacyclovir Hcl | 12 | $530 |
| Triamcinolone Acetonide | 16 | $202 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Kihei
- John KnoxKihei$1K
- Sarah HowellHonolulu$653K
- Douglas JohnsonHonolulu$568K
- Wayne FujitaAiea$385K
- Monica ScheelKailua Kona$253K
- Ryan SatoHonolulu$226K
- Rebecca LuriaKailua$23K
- Greg SakamotoHonolulu$20K
- Kory KitagawaHonolulu$18K
- Kevin DawsonHonolulu$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.